STATE OF FLUX
2014 GLOBAL SRM RESEARCH REPORT
CASE STUDY 37
This case study looks at how AstraZeneca re-assessed the effectiveness of their global supplier management approach and, to some degree, went back to basics to establish the right foundations.
CASE STUDY
In this case study we talk to John Hudson, Supplier Management Leader at AZ to learn how they re-shaped their approach to procurement and supplier management globally, and how they went back to basics to ensure the right foundations were in place. John has been Supplier Management Leader at AZ since 2012. He is responsible for the management and development of AZ’s procurement methodology (now called iProcure). Over the past two years, John has led a refresh and re-launch of this methodology and its ongoing roll-out has positioned AZ amongst the emerging leaders in our recent SRM studies. We put a number of questions to John to discover how AZ has approached this challenge, what progress has been made so far and what the future holds.
AstraZeneca (AZ) is one of only a handful of pure- play biopharmaceutical companies to span the entire value chain of a medicine – from discovery, through early- and late-stage development, to manufacturing, distribution, and the global commercialisation of primary care and specialty care medicines that transform lives. AZ is a global company with the need for a constantly evolving and effective procurement and supplier management strategy. AZ employs around 51,500 people worldwide: 34.8% in Europe, 21.7% in North America, 6% in Central and South America, 4.1% in the Middle East and Africa, and 33.4% in Asia Pacific. Manufacturing in 16 and working in 100 countries, their medicines are used by millions of patients worldwide. In 2013, global sales totalled $26 billion.
John Hudson Supplier Management Leader – AstraZeneca
Powered by FlippingBook